1. Home
  2. OVID vs DXST Comparison

OVID vs DXST Comparison

Compare OVID & DXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OVID
  • DXST
  • Stock Information
  • Founded
  • OVID 2014
  • DXST 2011
  • Country
  • OVID United States
  • DXST China
  • Employees
  • OVID N/A
  • DXST N/A
  • Industry
  • OVID Biotechnology: Pharmaceutical Preparations
  • DXST
  • Sector
  • OVID Health Care
  • DXST
  • Exchange
  • OVID Nasdaq
  • DXST NYSE
  • Market Cap
  • OVID 20.6M
  • DXST 18.7M
  • IPO Year
  • OVID 2017
  • DXST 2025
  • Fundamental
  • Price
  • OVID $0.33
  • DXST $1.28
  • Analyst Decision
  • OVID Strong Buy
  • DXST
  • Analyst Count
  • OVID 4
  • DXST 0
  • Target Price
  • OVID $3.13
  • DXST N/A
  • AVG Volume (30 Days)
  • OVID 1.7M
  • DXST 26.8K
  • Earning Date
  • OVID 08-12-2025
  • DXST 01-01-0001
  • Dividend Yield
  • OVID N/A
  • DXST N/A
  • EPS Growth
  • OVID N/A
  • DXST 13.11
  • EPS
  • OVID N/A
  • DXST 0.14
  • Revenue
  • OVID $548,000.00
  • DXST $11,542,292.00
  • Revenue This Year
  • OVID N/A
  • DXST N/A
  • Revenue Next Year
  • OVID $5.32
  • DXST N/A
  • P/E Ratio
  • OVID N/A
  • DXST $8.17
  • Revenue Growth
  • OVID 15.61
  • DXST 22.18
  • 52 Week Low
  • OVID $0.24
  • DXST $0.85
  • 52 Week High
  • OVID $1.47
  • DXST $5.74
  • Technical
  • Relative Strength Index (RSI)
  • OVID 55.40
  • DXST N/A
  • Support Level
  • OVID $0.29
  • DXST N/A
  • Resistance Level
  • OVID $0.35
  • DXST N/A
  • Average True Range (ATR)
  • OVID 0.03
  • DXST 0.00
  • MACD
  • OVID 0.00
  • DXST 0.00
  • Stochastic Oscillator
  • OVID 74.23
  • DXST 0.00

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

About DXST DECENT HOLDING INC

Decent Holding Inc through its subsidiary specializes in the provision of wastewater treatment by cleansing the industrial wastewater, ecological river restoration and river ecosystem management by enhancing the water quality, as well as microbial products used for pollutant removal and water quality enhancement. Its main services and products include (1) wastewater treatment, (2) river water quality management, and (3) microbial products for water quality enhancement and pollutant cleansing purposes. The company's focus is on research and development (R&D) to sharpen its innovation edge.

Share on Social Networks: